PharmaLegacy Laboratories

PharmaLegacy Laboratories is a leading specialty pharmacology contract research organization (CRO) providing comprehensive preclinical in vivo and in vitro pharmacology services. They offer over 1,500 validated animal models across more than 40 disease areas to support early proof-of-concept studies and regulatory submissions for pharmaceutical, biotech, and medical device companies worldwide. Their expertise includes oncology (immuno-oncology), inflammation/autoimmune diseases, bone metabolism/orthopaedics/tissue engineering, liver/metabolic diseases, PK/PD studies, molecular pharmacology assays, toxicology assessments (non‑GLP), and biocompatibility testing. The company operates internationally accredited vivarium facilities with large capacity for rodents and non-human primates. In recent years they have expanded into North America through the acquisition of BTS Research[1][2][3][7].